Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

about

Development and optimization of a novel drug free nanolipid vesicular system for treatment of osteoarthritis.

P2860

Q50054138-C0240836-D938-4AC5-B530-EB3C7B26CE0C

P2860

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

Item

http://www.wikidata.org/entity/Q39226726

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

@en

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

@nl

type

Item

label

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

@en

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

@nl

prefLabel

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

@en

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

@nl

P1476

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

@en

P2093

Chris Towery

http://www.w3.org/2001/XMLSchema#string

Saeid Davani

http://www.w3.org/2001/XMLSchema#string

Tony L Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

Diclofenac, a Non-steroidal Anti-inflammatory Drug, Inhibits L-type Ca Channels in Neonatal Rat Ventricular Cardiomyocytes.

A Review of Topical Diclofenac Use in Musculoskeletal Disease.

Oral versus topical NSAIDs in rheumatic diseases: a comparison.

Epidemiology of osteoarthritis

Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis.

American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.

OARSI guidelines for the non-surgical management of knee osteoarthritis.

Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis

P304

113-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15360288.2017.1301616

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vinicius Tieppo Francio

P577

2017-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28388238

http://www.w3.org/2001/XMLSchema#string

P921

diclofenac

osteoarthritis

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

about

P2860

P2860

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921